Form 4 for NDRA ENDRA Life Sciences Inc.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001209191-23-031298 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-22 | 2023-05-18 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $1.65 | +15.0K | 34.1K | +78% | +$24.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | P | A | 15,000 | $1.65 | 34,139 | D | — | — |